#Clearview healthcare partners serial number#
As reported in the latest trademark submission with a serial number 85029712, Clearview Healthcare Partners LLC can be reached at: Newton, MA, 02458, address - Suite 405, One Newton Place, 275 Washington Street.
1, 2021 /PRNewswire/ - RLH Equity Partners is pleased to announce that GHO Capital Partners LLP, a European specialist investor in global healthcare, has acquired a majority ownership position in RLH's portfolio company. It is dead/cancelled (cancelled - section 8) trademark (serial number 76233653) registered on. ClearView Healthcare Partners Recapitalized by GHO Capital. The subsequent trademark mentioned filed by Clearview Healthcare Partners LLC on includes the identification "CLEARVIEW PROJECTS". He has been a consultant to leading biopharmaceutical firms and their investors since 1997 and currently serves on the board of directors of Abkine Pharmaceuticals. The trademark was filed on with a serial number 77393067. Kevin is a co-founder of ClearView Healthcare Partners with over 25 years of experience in the life sciences industry. The second trademark is dead/abandoned (abandoned-failure to respond or late response) and is identified as "CLEARVIEW HEALTHCARE PARTNERS". Trademark's identification is "CLEARVIEW HEALTHCARE PARTNERS". Clearview Healthcare Partners LLC trademarks include: live/registered (section 8 & 15-accepted and acknowledged) trademark filed on and registered on. The Ropes & Gray team that advised GHO Capital was led by private equity partner Timothy Castelli (Chicago), and included tax partner Elaine Murphy (Boston), employment, executive compensation & benefits partner Jennifer Cormier (Boston), private equity partner Neill Jakobe (Chicago) and private equity associate Raxit Shah (Chicago), finance partners Alexander Robb (London) and Alexander Zeltser (New York), litigation & enforcement partner Timothy Farrell (Chicago), litigation & enforcement counsel Steven Kaye (Boston), finance counsel Nichole Lopez-Tackett (Chicago), life sciences regulatory & compliance partner Albert Cacozza (Washington D.C.), health care partner Christina Bergeron (Boston), IP transactions partner Violetta Kokolus (New York), antitrust partner Samer Musallam (Washington D.C.) and mergers & acquisitions counsel Thomas Burke (New York).As far as we managed to establish, the Patent and Trademark Office reports that 3 trademarks filed on behalf of Clearview Healthcare Partners LLC can be found. The Winston & Strawn team included Steven J. RLH Equity Partners invests, together with entrepreneurial leadership teams, in uniquely positioned, high growth, knowledge-based enterprises. ClearView is set to continue driving significant organic growth, cross selling emerging solutions, including data analytics and pricing & market access, to expand an existing client base while leveraging relationships to broaden capabilities across the small and mid-cap life sciences. ClearView, the leading independent strategy consulting firm focused on the life sciences, provides high-value guidance to its clients in connection with key decision points in the development and commercialization process and the management of growth and innovation across clients’ entire clinical and commercial portfolios.ĬlearView’s clients encompass a wide range of enterprises throughout the Big Pharma, Biopharma, Diagnostics, and MedTech sectors.
GHO Capital Partners is a European specialist investor in global healthcare. RLH Equity Partners announced that GHO Capital Partners LLP, a European specialist investor in global healthcare, has acquired a majority ownership position in RLH’s portfolio company, ClearView Healthcare Partners from RLH and ClearView management. Ropes & Gray advised Global Healthcare Opportunities. Winston & Strawn LLP represented RLH Equity Partners and the other equity holders of ClearView Healthcare Partners in the transaction.
0 kommentar(er)
